Enrique Grande, Head of Oncology at MD Anderson Cancer Center, posted on LinkedIn:
“Online Adaptive Radiotherapy enables a safe shift from conventional to hypofractionated schedules for bladder preservation.
- POD-ART mitigates toxicity, even with concurrent gemcitabine
- Comparable oncologic outcomes between ConvRT and HypoRT
- Supports wider adoption of HypoRT in MIBC.”
“Online Adaptive Radiotherapy enables a safe shift from conventional to hypofractionated schedules for bladder preservation.”
Authors: Anuradha Krishnan, Priyamvada Maitre, Sheetal Kashid, Namrata Pansande, Maneesh Singh, Pallavi Singh, Sakshi Dubey, Reena Phurailatpam, Divya Patil, Amit Joshi, Ankit Misra, Amandeep Arora, Mahendra Pal, Gagan Prakash, Vedang Murthy
